KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 159 filers reported holding KITE PHARMA INC in Q2 2015. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $13,529,000 | -34.1% | 130,498 | -50.1% | 0.04% | -34.4% |
| Q1 2017 | $20,515,000 | +130.2% | 261,377 | +80.7% | 0.06% | +125.9% |
| Q4 2015 | $8,911,000 | +193.6% | 144,611 | +174.9% | 0.03% | +237.5% |
| Q1 2015 | $3,035,000 | -30.3% | 52,613 | -30.3% | 0.01% | -27.3% |
| Q4 2014 | $4,352,000 | – | 75,469 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $185,086,000 | 58.62% |
| BAINCO INTERNATIONAL INVESTORS | 879,840 | $69,059,000 | 9.77% |
| Coastal Bridge Advisors, LLC | 235,140 | $18,456,000 | 6.29% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,433,899 | $112,547,000 | 5.71% |
| NEXTHERA CAPITAL LP | 105,000 | $8,241,000 | 4.20% |
| ARK Investment Management | 87,364 | $6,857,000 | 1.98% |
| Casdin Capital, LLC | 42,500 | $3,336,000 | 1.97% |
| BB BIOTECH AG | 740,000 | $58,083,000 | 1.90% |
| FT Options LLC | 81,700 | $1,287,000 | 1.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 55,500 | $4,346,000 | 1.66% |